• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of August 14, 2013

  • Print
  • Share
  • E-mail

Product Detail

Product Description Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30
Recall Number D-841-2013
Classification Class II
Code Info Lot # 3097657, Exp 3/15
Product Distributed Qty 2,462 bottles
Reason For Recall Subpotent drug: low fill volume in some of the capsules

Event Detail

Event Id 65701
Product Type Drugs
Status Ongoing
Recalling Firm Sanofi US
City Bridgewater
State NJ
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2013-03-07
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Nationwide